The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non‐small cell lung cancer

The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non‐small cell lung cancer

Abstract Background Systemic inflammation, the most representative tumour–host interaction, plays a crucial role in disease progression and prognosis in patients with non‐small cell lung cancer (NSCLC). Few studies have compared the performance of existing haematological systemic inflammation biomar...

Full description

Bibliographic Details
Main Authors: Hailun Xie, Guotian Ruan, Lishuang Wei, Li Deng, Qi Zhang, Yizhong Ge, Mengmeng Song, Xi Zhang, Shiqi Lin, Xiaoyue Liu, Ming Yang, Chunhua Song, Xiaowei Zhang, Hanping Shi
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Systemic inflammation
Biomarker
Prognosis
Cachexia
Expenses
Non‐small cell lung cancer
Online Access:https://doi.org/10.1002/jcsm.13199

Internet

https://doi.org/10.1002/jcsm.13199

Similar Items